Tobias A. Moll

Sheffield, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications

Single-nucleus multiomic atlas of ALS primary motor cortex nominates neuroprotective WDR49-expressing astrocytes.

Single-nucleus multiomic atlas of ALS primary motor cortex nominates neuroprotective WDR49-expressing astrocytes.

Journal: Research square
Published: June 12, 2026

Single-nucleus multiomic atlas of ALS primary motor cortex nominates neuroprotective WDR49-expressing astrocytes.

Single-nucleus multiomic atlas of ALS primary motor cortex nominates neuroprotective WDR49-expressing astrocytes.

Journal: Research square
Published: June 12, 2026

Striatal neuron dysfunction in C9ORF72-FTD/ALS is driven by AIS and potassium channel dysregulation.

Striatal neuron dysfunction in C9ORF72-FTD/ALS is driven by AIS and potassium channel dysregulation.

Journal: Cell reports
Published: October 29, 2025

Hypothesis-free evaluation of circulating metabolome provides cell-specific insights regarding the role of energy substrate availability in amyotrophic lateral sclerosis.

Hypothesis-free evaluation of circulating metabolome provides cell-specific insights regarding the role of energy substrate availability in amyotrophic lateral sclerosis.

Journal: BMC medicine
Published: October 08, 2025

Paraspeckle condensation is controlled via TDP-43 polymerization and linked to neuroprotection.

Paraspeckle condensation is controlled via TDP-43 polymerization and linked to neuroprotection.

Journal: Nature cell biology
Published: March 03, 2025

Evaluation of a biomarker for amyotrophic lateral sclerosis derived from a hypomethylated DNA signature of human motor neurons.

Evaluation of a biomarker for amyotrophic lateral sclerosis derived from a hypomethylated DNA signature of human motor neurons.

Journal: Research square
Published: December 09, 2024

An observational study of pleiotropy and penetrance of amyotrophic lateral sclerosis associated with CAG-repeat expansion of ATXN2.

An observational study of pleiotropy and penetrance of amyotrophic lateral sclerosis associated with CAG-repeat expansion of ATXN2.

Journal: European journal of human genetics : EJHG
Published: November 08, 2024

Evaluation of a biomarker for amyotrophic lateral sclerosis derived from a hypomethylated DNA signature of human motor neurons.

Evaluation of a biomarker for amyotrophic lateral sclerosis derived from a hypomethylated DNA signature of human motor neurons.

Journal: BMC medical genomics
Published: November 05, 2024

Non-coding genome contribution to ALS.

Non-coding genome contribution to ALS.

Journal: International review of neurobiology
Published: May 27, 2024

Antisense oligonucleotide depletion of CCDC146 is a broad-spectrum therapeutic strategy for ALS.

Antisense oligonucleotide depletion of CCDC146 is a broad-spectrum therapeutic strategy for ALS.

Journal: medRxiv : the preprint server for health sciences
Published: April 18, 2024

Stress-induced TDP-43 nuclear condensation causes splicing loss of function and STMN2 depletion.

Stress-induced TDP-43 nuclear condensation causes splicing loss of function and STMN2 depletion.

Journal: Cell reports
Published: January 10, 2024

Rare and common genetic determinants of mitochondrial function determine severity but not risk of amyotrophic lateral sclerosis.

Rare and common genetic determinants of mitochondrial function determine severity but not risk of amyotrophic lateral sclerosis.

Journal: Heliyon
Published: June 19, 2023
Showing 1-12 of 28

Last Updated: 09/26/2026